Ion Beam Applications
13.32
24-December-24 04:20:29
15 minutes delayed
Stocks
-0.02
-0.15%
Today's range
13.32 - 13.32
ISIN
BE0003766806
Source
Cboe
-
IBA and SCK CEN launch Pantera, a joint-venture to produce actinium-225
22 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
20 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Half Year 2022 Results
31 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA and ScandiDos form strategic alliance to increase access to safe radiotherapy
30 Aug 2022 12:00:00 By Nasdaq GlobeNewswire
-
26 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
02 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
30 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
01 Jun 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Business Update – First Quarter 2022
19 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA continues to shape the future of proton therapy at ESTRO 2022 Annual Congress
06 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China
05 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc.
03 May 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
22 Apr 2022 00:55:00 By Nasdaq GlobeNewswire
-
IBA and UMC Groningen engage in FLASH irradiation research collaboration for breast cancer
05 Apr 2022 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Full Year 2021 Results
24 Mar 2022 02:00:00 By Nasdaq GlobeNewswire
-
IBA and Tractebel announce partnership to support proton therapy construction projects
15 Mar 2022 10:00:00 By Nasdaq GlobeNewswire
-
IBA – ACQUISITION OF OWN SHARES COMPLETION OF THE SHARE BUYBACK PROGRAM
10 Mar 2022 13:25:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
08 Mar 2022 13:20:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
07 Mar 2022 12:32:00 By Nasdaq GlobeNewswire
-
Iba – Acquisition of Own Shares
28 Feb 2022 12:27:00 By Nasdaq GlobeNewswire